Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/1999
03/01/1999CA2242311A1 Novel compounds
02/1999
02/28/1999CA2241427A1 Novel pyrr homolog
02/26/1999CA2241431A1 Novel spoiiie
02/25/1999WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999WO1999009061A1 Secreted proteins
02/25/1999WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
02/25/1999WO1999008728A1 Composition and device for in vivo cartilage repair
02/25/1999WO1998047866A3 Arylsecocholadiene derivatives
02/25/1999DE19736772A1 New guanidino-substituted bi:cyclic peptide compounds
02/25/1999CA2300093A1 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
02/25/1999CA2241392A1 Pigr-2, a member of immunoglobulin gene superfamily
02/24/1999EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor
02/24/1999EP0897979A2 Human sdr2 cdna clone
02/24/1999EP0897390A1 Human tumor necrosis factor delta and epsilon
02/24/1999CN1209123A New barbituric acid derivatives, processes for their prodn. and pharmaceutical agent contg. same
02/24/1999CN1209064A Combination therapy for osteoporosis
02/24/1999CN1209063A Vitronection receptor antagonists
02/24/1999CN1209060A Vitronectin receptor antagonists
02/24/1999CN1208648A Chinese herb medicine allicin health-care liquid
02/24/1999CN1208644A Medicine for treating diseases such as rheumatic arthritis, rheumatoid arthritis and scapulohmeral periarthritis
02/24/1999CN1208626A Traditional Chinese medicine bolus for strengthening bones of human body and method for preparing same
02/23/1999US5874573 Cyclic amine derivatives
02/23/1999US5874566 Il-15 triplex oligonucleotides
02/23/1999US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences
02/23/1999US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor
02/23/1999US5874245 Human G-protein coupled receptor (HIBCD07)
02/23/1999US5874243 OLRCC15 receptor
02/23/1999US5874224 Growth factor receptor binding protein
02/23/1999US5874086 Synthetic polypeptide analogs of parathyroid hormone (pth), parathyroid hormone related peptide (pthrp), and of the physiologically active truncated homologs and analogs of pth and pthrp; forming an amphipathic alpha-helix
02/20/1999CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor
02/18/1999WO1999007737A2 Lsr receptor, cloning and uses
02/18/1999WO1999007736A2 Lipoprotein-regulating medicaments
02/18/1999WO1999007693A1 Benzothiophenes
02/18/1999WO1999007681A1 2-acylaminopropanamines as tachykinin receptor antagonists
02/18/1999WO1999007668A1 Non-steroidal ligands for the estrogen receptor
02/18/1999WO1999007351A2 Indole derivatives and their use as mcp-1 antagonists
02/18/1999CA2299309A1 Benzothiophenes
02/18/1999CA2298849A1 Lipoprotein-regulating medicaments
02/18/1999CA2298702A1 2-acylaminopropanamines as tachykinin receptor antagonists
02/18/1999CA2297290A1 Chemical compounds
02/18/1999CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
02/17/1999EP0897011A2 Novel arginine deiminase
02/17/1999EP0897008A2 His5
02/17/1999EP0896825A1 Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors
02/17/1999CN1208351A Composition containing diosgenin
02/17/1999CN1208033A Colchicine and thiocolchicine derivatives with anti-inflammatory and muscle relaxant activities
02/17/1999CN1207931A Hyperosteogeny plaster
02/17/1999CN1207928A Traumatic injury plaster
02/17/1999CN1207927A Plaster for periarthritis of shoulder joint
02/16/1999US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor
02/16/1999US5871729 Superoxide dismutase-4
02/15/1999CA2224096A1 The g-protein coupled receptor hfia041
02/12/1999CA2239835A1 Human sdr2 cdna clone
02/11/1999WO1999006563A1 Novel bone mineralization proteins, dna, vectors, expression systems
02/11/1999WO1999006434A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999WO1999006426A1 Novel molecules of the tango-77 related protein family and uses thereof
02/11/1999WO1999006423A1 83 human secreted proteins
02/11/1999WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
02/11/1999WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999WO1999006367A1 Caspases and apoptosis
02/11/1999WO1999006361A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
02/11/1999WO1999006354A1 Il-8 receptor antagonists
02/11/1999WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
02/11/1999WO1999006051A1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
02/11/1999WO1999006042A1 Caspases and apoptosis
02/11/1999WO1999006041A1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS
02/11/1999CA2299055A1 Novel molecules of the tango-77 related protein family and uses thereof
02/11/1999CA2298852A1 83 human secreted proteins
02/11/1999CA2298668A1 Caspases and apoptosis
02/11/1999CA2298617A1 Acyclic metalloprotease inhibitors
02/11/1999CA2297757A1 Caspases and apoptosis
02/11/1999CA2297489A1 Novel bone mineralization proteins, dna, vectors, expression systems
02/11/1999CA2295295A1 Substituted alkanohydroxamic acids and method of reducing tnf.alpha. levels
02/11/1999CA2294064A1 Il-8 receptor antagonists
02/11/1999CA2290750A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999CA2290746A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999CA2239836A1 Novel arginine deiminase
02/11/1999CA2239813A1 Novel nrdd
02/11/1999CA2239221A1 Novel his5
02/10/1999EP0895475A1 Vitronectin receptor antagonists
02/10/1999EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
02/10/1999CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme
02/10/1999CN1207734A Metalloproteinase inhibitors, pharmaceutical compositions contg. them and their pharmaceutical uses, and methods and intermediates useful for their preparation
02/10/1999CN1207724A Amino alcohol derivs., method of producing said derivs., and medicaments contg. them
02/10/1999CN1207320A Calcium antagonist having parathyroid hormone secretion inhibition, preparing method and use thereof
02/10/1999CN1207319A Medicine for treating osteoproliferation, rheumatism and rheumatoid arthritis, and preparing method thereof
02/10/1999CN1207307A Bone-knitting pill and producing process thereof
02/10/1999CN1042031C Quaternary nitrogen-contg. phosphonate compounds, pharmaceutical compositions and use thereof
02/09/1999US5869663 Intermediates for neurokinin receptor antagonists
02/09/1999US5869471 Methods for the treatment of arthritis using phosphonates and NSAIDS
02/09/1999US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/09/1999CA2226091C Cyclosporin-containing soft capsule preparations
02/05/1999CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses
02/05/1999CA2239270A1 Novel phosphoribosyl transferase
02/04/1999WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS
02/04/1999WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS
02/04/1999WO1999005113A1 Substituted 6-phenylphenanthridines
02/04/1999WO1999005112A1 Substituted 6-alkylphenanthridines